Romuald Corbau

I obtained a European PhD in Biochemistry in 1998 for my work on the interaction between host cell and the viral life cycle. I joined Pfizer in June 1998 and my initial appointment was in the Anti-infectives department, where I participated in the anti-viral drug discovery programme (HIV and HCV); ultimately leading the programme that resulted in the discovery of UK-453,061 (lersvirine, currently in Phase IIb clinical development). I have worked on all aspect of anti-viral drug discovery from the generation of idea up to phase I clinical trial (FIH), working on both small molecule and biological (antibody and gene therapy). I am currently Associate Research Fellow, where I my main responsibilities consist of the leadership and delivery of a first in patient study (FPFV in 2011). As part of the Internal Medicine Unit leadership team my other responsibilities include scientifically reviewing the portfolio of the department as well as strategically establishing a portfolio focussed on liver disease. I have over 16 years’ experience in Biomedical Research, out of which 12 are in the pharmaceutical industry. I have published fifteen scientific papers and am co-inventor on several method and composition of matter patent applications. I also have extended my contribution outside of our anti-viral department by applying my knowledge of the biological field as well as my managerial skills – these have contributed directly to the establishment of a Biotherapeutic department at Sandwich, and to the development of our external strategy for the New Opportunity department.